Drug Research
Gene-Edited Neutrophils Show Potential Against Lung Cancer
In Hong Kong, lung cancer continues to be the most prevalent form of cancer. Despite its status as a prominent global cause of cancer-related deaths, there is still a need for a significant breakthrough in its treatment. The Faculty...
Drug Research
Telix Opens $21.2M European Radiopharmaceutical Production Facility
Telix Pharmaceuticals Limited opened Telix Manufacturing Solutions, the company's radiopharmaceutical production facility located in Belgium.
The 2,800 square meter facility is one of Europe's largest radiopharmaceutical production facilities, according to the company. It will serve as Telix’s primary manufacturing site...
Drug Research
Charles River and INADcure Announce Gene Therapy Manufacturing Collaboration
Charles River Laboratories International, Inc. and the INADcure Foundation, a nonprofit organization whose mission is to support the development of treatments for Infantile Neuroaxonal Dystrophy (INAD) and other forms of PLA2G6-related neurodegeneration (PLAN), today announced a plasmid DNA manufacturing...
Drug Research
Quell Therapeutics, AstraZeneca Partner on Engineered Treg Cell Therapies
Quell Therapeutics Ltd, a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announced that it has entered into a collaboration, exclusive option and license agreement with AstraZeneca to develop, manufacture...
Drug Research
Pharma Dealmaking Recovery Gets Boosted By $85bn M&A Splurge
It is well to be noted that pharma and biotech companies splurged a whopping $85 billion in the first five months of 2023, which itself went on to mark a dramatic recovery when it comes to dealmaking as they...
BioPharma
Lack of Experience Hinders CDMOs In Cell And Gene Therapy
CDMOs (contract development and manufacturing organizations) are facing challenges due to the increasing number of companies preparing to scale up their cell and gene therapy manufacturing for Phase III trials and commercialization. While physical capacity has been blamed, the...
News
Corning and SGD Pharma announce joint venture to open new glass tubing facility and expand access to Corning Velocity Vial technology in India
Corning Incorporated and SGD Pharma announced a joint venture that includes the opening of a new glass tubing facility to expand pharmaceutical manufacturing in India and allows SGD Pharma to adopt Corning’s Velocity® Vial technology platform.
Combining SGD Pharma’s vial-converting expertise with Corning’s proprietary glass-coating technology, the collaboration will enhance vial quality,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read